ASP Isotopes Inc. [NASDAQ:ASPI] is an advanced materials company that develops technology for the enrichment of isotopes used in various sectors. On April 10, 2026, the company reported its quarterly financial results. The report presented a mixed performance, with ASPI missing its earnings target but beating revenue expectations.
The company posted an earnings per share (EPS) of -$0.84, falling short of the analyst consensus estimate of -$0.14. EPS is a measure of a company's profit divided by its outstanding shares. A negative figure, like ASPI's, indicates the company had a net loss for the period.
On a positive note, ASPI's revenue for the quarter came in at $2.3 million, surpassing the estimated $2.03 million. This revenue figure contributes to its price-to-sales ratio of 15.61. A high ratio like this often suggests that investors expect strong future sales growth, even if the company is not yet profitable.
The recent loss is also reflected in its negative price-to-earnings (P/E) ratio of -2.40. However, in a business update highlighted by GlobeNewswire, ASPI outlined a path toward future growth. The company expects to begin its first commercial shipments in 2026 and is targeting an EBITDA of over $300 million in 2031.
Despite its current unprofitability, ASPI maintains a strong financial position with $333 million in cash and equivalents. Its current ratio stands at 12.18, which indicates it has ample liquid assets to cover its short-term liabilities. This provides the company with the financial flexibility to fund its operational goals.
